Heard On The Street: Delhivery Faces Sell-Off, Mphasis Sees Big HNI Buys
Suprajit Engineering rose on dealer talk of interest in its new business, while Trent fell as the street grew cautious over inventory levels.

Markets staged a strong rebound on Tuesday after Monday’s sharp fall, with realty and PSU bank stocks leading the recovery. The Nifty 50 and the Sensex hit intraday highs of 22,635.25 and 74,682.85 respectively, rising 2.14% and 1,544.95 points as of 12:44 p.m.
The wild sways that rattled markets has subsided on Tuesday, as investors across Asia sought out dip-buying opportunities while waiting for clarification on how President Donald Trump's trade plans would play out.
NDTV Profit picked up the following cues from dealing room chatter during trade:
Max Healthcare
There is buzz of potential block deal in Max Healthcare Ltd. by a FII very soon.
Delhivery
Dealers flagged selling pressure from a foreign emerging market investor. The stock saw consistent sell flows through the morning session, though dealers expect the overhang to clear soon.
Trent
After opening firm, Trent Ltd. slipped over 4% intraday. According to dealers, the street is concerned about potential inventory build-up, which may weigh on margins in upcoming quarters.
Mphasis And Coforge
Mphasis Ltd. and Coforge Ltd. saw sustained buying interest from high net-worth investors. Dealers believe these are likely positional trades, coming on the back of strong momentum in IT stocks. The Nifty IT index is among the top three sectoral gainers in trade.
Suprajit Engineering
Suprajit Engineering Ltd. announced its entry into the anti-lock braking system segment. Dealers picked up talk of early interest from two potential customers, though names were not confirmed.
Disclaimer: The mentioned stocks capture NDTV Profit's dealing room channel checks during trading hours. The information provided is for informational purposes. However, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, or suitability of the information. This content does not constitute financial, investment, or trading advice and should not be construed as a recommendation to buy, sell, or hold any securities.